检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]滨州市人民医院检验科,山东省滨州256610
出 处:《中国基层医药》2012年第13期1964-1965,共2页Chinese Journal of Primary Medicine and Pharmacy
摘 要:目的探讨血小板相关抗体对血小板输注效果的影响。方法采用酶联免疫吸附试验(ELISA)检测120例长期反复输血并且需要输注血小板患者的血小板相关抗体,检测输血前后血小板计数,采用血小板计数增值考察血小板输注效果。采用简易致敏红细胞血小板血清学技术(SEPSA)对血小板相关抗体阳性患者进行血小板交叉配型后进行血小板输注。结果反复输血的患者中血小板相关抗体阳性率为65.0%,血小板输注的有效率为61.7%。血小板相关抗体阳性患者和阴性患者输注血小板时输注无效率分别为84.6%和19.0%,差异有统计学意义(x2=46.914,P〈0.01)。对血小板相关抗体阳性患者采用SEPSA进行血小板配型后输注血小板有效率为85.9%。结论血小板相关抗体阳性与血小板输注无效相关,血小板配型可有效提高临床输注效果。Objective To investigate effect of platelet-associated antibody to the platelet transfusion. Methods Platelet-associated antibody in 120 patients who needed repeated platelet transfusion for long-time was de- termined by enzyme-linked immunosorbent assay ( ELISA), and platelet count was assayed before and after blood transfusion, and the effect of platelet transfusion was investigated by corrected platelet count. Crossmatch approcah was used to screen compatible platelet for patients with piatelet relative antibody positive. Results The ratio of positive platelet-assoeiated antibody in patients who needed repeated platelet transfusion was 65.0% , and the ratio of platelet transfusion resistance was 61.7%. The ratios of platelet transfusion resistance were 84.6% and 19.0% respectively in patients with positive platelet-associated antibody and in patients with negative platelet-associated antibody, which were different in statistic in both groups( X2 = 46. 914 ,P 〈 0.01 ). The effective ratio of platelet transfusion in patients with positive platelet-associated antibody after crossmatcb approach was 85.9%. Conclusion Positive platelet-asso- ciated antibody was related to platelet transfusion resistance with high risk, and erossmatcb approach could increase the effect of platelet transfusion.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.91